Heinrichs W, Weiler N
Klinik für Anästhesiologie, Johannes Gutenberg-Universität Mainz.
Anaesthesist. 1993 Sep;42(9):612-8.
In the postoperative period patients are at risk of excessive oxygen consumption (VO2). However, patients suffering from cardiovascular disease may be unable to increase their oxygen transport capacity sufficiently and may be especially vulnerable to tissue hypoxia as part of the reaction to intraoperative stress. During the last 10 years conflicting results concerning the benefits of a combined epidural and light general anaesthesia have been published. Some of the results indicate that postoperative catabolism may be depressed and that the neuroendocrine response to stress may be inhibited by such a combined technique. We studied the effect of a combined epidural and light general anaesthesia on VO2 in the early post-operative period. PATIENTS AND METHODS. Three groups of patients were studied: group 1 contained 10 patients scheduled for major urological procedures of at least 3 h duration who received a combined epidural and light general anaesthesia. Group 2 contained 17 patients with procedures comparable to group 1 but received a standard general anaesthesia with isoflurane, N2O and fentanyl. In addition, 13 patients undergoing minor urological procedures of less than 2 h duration and undergoing standard general anaesthesia were included in the study as a control group (group 3). All patients gave informed consent. Preoperative management was the same in the three groups. Perioperative risk was assessed according to the ASA classification. In group 1 patients, an epidural catheter was placed preoperatively at the L3/4 interspace and tested for correct positioning using 4 ml of 2% mepivacaine with epinephrine 1:200,000. After induction of anaesthesia an epidural block was established with 0.5% bupivacaine for intraoperative analgesia and 0.25% bupivacaine for postoperative pain relief. The initial dosage was determined (according to Bromage's method) to reach a sensory level of T-6. Two-thirds of the initial dose was the given on two occasions, each 90 min after the dose before. End-tidal isoflurane concentrations ranged between 0.3 and 0.6 vol% in this group. In groups 2 and 3, endtidal isoflurane concentrations of 1.0 to 1.5 vol% were applied. Postoperative analgesia was achieved in these groups using repeated doses of 7.5 mg piritramide i.v. Oxygen consumption was measured in the recovery room using the Deltatrac (Datex) metabolic monitor. Measurements were performed with a canopy room air dilution technique. Arterial oxygen saturation of the patients was monitored continuously using pulse oximetry. Data acquisition was started within 10 min after extubation and continued for at least 60 min until a steady state of oxygen consumption was reached. We recorded the average VO2 during the initial 5 min of the measurement period and during another 5-min period after the steady state was reached (45-60 min after extubation). RESULTS. Patients in the three groups were comparable in age, height and body weight (Table 1). The duration of procedures in groups 1 and 2 ranged between 4 and 7 h. Groups 1 and 2 were further comparable in terms of intraabdominal procedures, intraoperative blood loss, fluid replacement, and fall in body temperature during the operation (Table 2). Heart range was significantly higher in group 2 during the 5-min test interval (Table 3). Figure 1 shows the typical course of oxygen consumption in patients of groups 1, 2, and 3. The readings in the group 1 patient as well as in the group 3 patients were stable throughout the observation period. Oxygen consumption was in the physiological range. In contrast, in the group 2 patients during the early postoperative period, increased values of VO2 (approx. 50% above normal) were observed. These findings were highly significant in our study. In the early postoperative period (5 min) patients in group 1 showed a VO2 or 3.6 +/- 0.4 ml.kg-1.min-1. This was the same as in group 3 (3.5 +/- 0.3 ml.kg-1.min-1). In contrast, in group 2 a VO2 of 5.3 +/- 0.7 ml.kg-1.min-1
术后患者存在氧耗量(VO2)过高的风险。然而,患有心血管疾病的患者可能无法充分提高其氧运输能力,并且作为对术中应激反应的一部分,可能特别容易发生组织缺氧。在过去10年中,关于硬膜外联合浅全身麻醉的益处已发表了相互矛盾的结果。一些结果表明,术后分解代谢可能受到抑制,并且这种联合技术可能会抑制对应激的神经内分泌反应。我们研究了硬膜外联合浅全身麻醉对术后早期VO2的影响。患者和方法。研究了三组患者:第1组包含10例计划进行至少3小时大型泌尿外科手术的患者,他们接受了硬膜外联合浅全身麻醉。第2组包含17例手术与第1组相当但接受异氟烷、N2O和芬太尼标准全身麻醉的患者。此外,13例接受持续时间少于2小时的小型泌尿外科手术并接受标准全身麻醉的患者被纳入研究作为对照组(第3组)。所有患者均给予知情同意。三组患者的术前管理相同。根据美国麻醉医师协会(ASA)分类评估围手术期风险。在第1组患者中,术前在L3/4间隙放置硬膜外导管,并使用4ml含1:200,000肾上腺素的2%甲哌卡因测试其正确位置。麻醉诱导后,用0.5%布比卡因建立硬膜外阻滞用于术中镇痛,用0.25%布比卡因用于术后疼痛缓解。初始剂量根据布罗梅奇方法确定,以达到T-6感觉平面。初始剂量的三分之二分两次给药,每次在给药前90分钟。该组患者的呼气末异氟烷浓度在0.3至0.6vol%之间。在第2组和第3组中,应用的呼气末异氟烷浓度为1.0至1.5vol%。这些组通过静脉重复给予7.5mg匹米诺定实现术后镇痛。在恢复室使用Deltatrac(Datex)代谢监测仪测量氧耗量。测量采用面罩室内空气稀释技术进行。使用脉搏血氧饱和度仪连续监测患者的动脉血氧饱和度。数据采集在拔管后10分钟内开始,并持续至少60分钟,直至达到氧耗量的稳定状态。我们记录了测量期最初5分钟以及达到稳定状态后(拔管后45 - 60分钟)另一个5分钟期间的平均VO2。结果。三组患者在年龄、身高和体重方面具有可比性(表1)。第1组和第2组的手术持续时间在4至7小时之间。第1组和第2组在腹部手术、术中失血、液体补充以及手术期间体温下降方面进一步具有可比性(表2)。在5分钟测试间隔期间,第2组的心率明显更高(表3)。图1显示了第1组、第2组和第3组患者氧耗量的典型变化过程。第1组患者以及第3组患者的读数在整个观察期内稳定。氧耗量处于生理范围内。相比之下,在术后早期,观察到第2组患者的VO2值升高(比正常高约50%)。这些发现在我们的研究中具有高度统计学意义。在术后早期(5分钟),第1组患者的VO2为3.6±0.4ml·kg-1·min-1。这与第3组相同(3.5±0.3ml·kg-1·min-1)。相比之下,第2组的VO2为5.3±0.7ml·kg-1·min-1